Home Stock

Stock Research: DongKook Pharmaceutical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

DongKook Pharmaceutical

KOSDAQ:A086450 KR7086450004
96
  • Value
    61
  • Growth
    90
  • Safety
    Safety
    62
  • Combined
    90
  • Sentiment
    75
  • 360° View
    360° View
    96
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

DongKook Pharmaceutical Co., Ltd. is a Korea-based company engaged in the development, manufacture, and distribution of pharmaceuticals. It operates in the pharmaceutical industry, providing remedies for oral troubles, skin troubles, gynecology diseases, contrast mediums, anesthetics, anticancer medicines, circulatory system agents, arthritis and pancreatitis remedies, antiphlogistic, anodynes, antibiotics, vitamins, and raw materials for pharmaceuticals, along with a rental business. The company distributes its products domestically and to overseas markets including Japan, Germany, India, Brazil, and Mexico. In the last fiscal year, the company had a market cap of $596 millions, profits of $303 millions, and revenue of $550 millions.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 96 (better than 96% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock DongKook Pharmaceutical are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for DongKook Pharmaceutical. The consolidated Value Rank has an attractive rank of 62, which means that the share price of DongKook Pharmaceutical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 62% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 90, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 61. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 75. ...read more

more
Country South Korea
Industry Pharmaceuticals
Size Small
Website dkpharm.co.kr
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
62 56 66 49
Growth
90 65 57 67
Safety
Safety
61 44 61 63
Sentiment
75 96 100 82
360° View
360° View
96 86 96 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
95 100 97 93
Opinions Change
15 77 89 96
Pro Holdings
n/a 76 90 6
Market Pulse
n/a n/a n/a n/a
Sentiment
75 96 100 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
62 56 66 49
Growth
90 65 57 67
Safety Safety
61 44 61 63
Combined
90 61 75 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
66 72 72 62
Price vs. Earnings (P/E)
75 78 78 61
Price vs. Book (P/B)
46 38 51 34
Dividend Yield
40 37 46 32
Value
62 56 66 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
83 75 74 69
Profit Growth
56 60 34 23
Capital Growth
71 50 64 90
Stock Returns
66 44 35 29
Growth
90 65 57 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
63 43 51 46
Refinancing
62 68 67 61
Liquidity
47 25 47 59
Safety Safety
61 44 61 63

Similar Stocks

Discover high‑ranked alternatives to DongKook Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Korea Investment

KOSE:A071050
Country: South Korea
Industry: Investment Banking & Brokerage
Size: Large
Full Stock Analysis

Kia Motors

KOSE:A000270
Country: South Korea
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Tsumura

TSE:4540
Country: Japan
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis
OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.